Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;42(5):324-5.
doi: 10.4103/0253-7613.70400.

Atorvastatin-induced pancreatitis

Affiliations

Atorvastatin-induced pancreatitis

Samir Prajapati et al. Indian J Pharmacol. 2010 Oct.

Abstract

Drugs account for 1-2% of all cases of pancreatitis. A 58-year-old man was prescribed atorvastatin 10 mg for 6 months for hyperlipidemia. He developed acute abdominal pain and vomiting with epigastric tenderness. Serum lipase and CT scan of the patient suggested the presence of acute pancreatitis. The patient was hospitalized; atorvastatin was stopped and treated symptomatically. He recovered completely within 10 days of drug withdrawal. The causality of the adverse drug reaction according to Naranjo and WHO-UMC Scale was probable. The exact mechanism of pancreatitis due to atorvastatin is not known. It may be a class effect of HMG CoA reductase inhibitors as it had been reported with other statins too. The definite causal relationship is difficult to establish, as rechallenge with the suspected drug was not done due to ethical consideration.

Keywords: Adverse drug reaction; atorvastatin; pancreatitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
CT scan shows head of the inflamed pancreas

References

    1. Singh S, Nautiyal A, Dolan J. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? J Pancreas (Online) 2004;5:502–4. - PubMed
    1. Hartwig S, Seigel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32. - PubMed
    1. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538. - PubMed
    1. McArthur KE. drug-induced pancreatitis. Aliment Pharmacol Ther. 1996;10:23–38. - PubMed
    1. Battillocchi B, Diana M, Dandolo R, Stefanini S, D’Amore L, Negro P. Drug-induced acute pancreatitis: A personal contribution. Chir Ital. 2002;54:605–12. - PubMed